# Anthony V. D'Amico

Source: https://onco.cc/people/anthony-damico/  
OnCo record `anthony-damico` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Created the low, intermediate and high-risk classification that every prostate cancer decision starts from.

## Summary

Anthony D'Amico developed the 1998 risk stratification of localised prostate cancer by PSA, Gleason score and stage that remains the backbone of guidelines and trial eligibility, and led the randomised trial showing six months of androgen deprivation with radiotherapy improves survival in intermediate and high-risk disease. He continues to publish on PSA kinetics and on tailoring hormone therapy duration.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: prostate; radiotherapy; risk-stratification
- Role: Professor of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute
- Specialisms: Prostate radiotherapy; Risk stratification; Androgen deprivation with radiotherapy

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=D'Amico%20AV%5BAuthor%5D%20prostate%20risk

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Androgen deprivation & AR pathway inhibitors](https://onco.cc/technologies/androgen-deprivation/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- institutions: [Dana-Farber Brigham Cancer Center](https://onco.cc/institutions/dana-farber/)

---
JSON: https://onco.cc/api/v1/entities/anthony-damico.json